Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period
May 1, 2018, 00:00
10.1016/j.jval.2018.04.328
https://www.valueinhealthjournal.com/article/S1098-3015(18)30628-4/fulltext
Title :
Clotting Factor (CF) Product Administration And Risk Of Thrombotic Adverse Events (TES) Among The Inpatient U.S. Elderly Medicare Beneficiaries, During 2009-2015 Study Period
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30628-4&doi=10.1016/j.jval.2018.04.328
First page :
Section Title :
Open access? :
No
Section Order :
1191